返回
AIM Vaccine Co., Ltd.（06660.HK）價格
06660.HK 股價走勢圖
AIM VACCINE (06660.HK)
AIM Vaccine Co., Ltd.
HK$3.69
-1.33%
$-0.05
休市： Jan 16, 16:00:00 HKT
關鍵數據
前收市價
$3.74
開盤價
$3.74
當日範圍
$3.67 - $3.78
52週區間
$3.03 - $6.55
交易量
535.0K
平均成交量
599.5K
每股盈餘 (TTM)
-0.26
股息收益率
--
市值
$1.8B
什麼是 AIM VACCINE？
AIM Vaccine Co., Ltd. engages in biological vaccine technology development, technology transfer, and technical services. The company is headquartered in Beijing, Beijing and currently employs 1,493 full-time employees. The company went IPO on 2022-10-06. The firm's commercialized products mainly include recombinant HBV vaccine, freeze dried human rabies vaccine, inactivated HAV vaccine, mumps vaccine, bivalent inactivated HFRS vaccine and Group A, C, Y and W135 MPSV. The firm's vaccine products under development include 13-Valent Pneumonia Conjugate Vaccine, 24-Valent Pneumonia Conjugate Vaccine, quadrivalent influenza virus vaccine, iterative serum-free rabies vaccine, mRNA shingles/herpes zoster vaccine, Iterative mRNA rabies vaccine, mRNA respiratory syncytial virus vaccine, novel-process highly-effective human diploid rabies vaccine, and others.